1. Osteoblastic and hyperostotic craniofacial lesion detected by 99mTc-labeled methylene diphosphonate bone scintigraphy and single-photon emission computed tomography/computed tomography: a pictorial essay
- Author
-
Frédéric Paycha and Huijun Ju
- Subjects
Male ,Hyperostosis ,Single Photon Emission Computed Tomography Computed Tomography ,Computed tomography ,Review Article ,Technetium Tc 99m Medronate ,Single-photon emission computed tomography ,030218 nuclear medicine & medical imaging ,Diagnosis, Differential ,Lesion ,03 medical and health sciences ,0302 clinical medicine ,craniofacial lesions ,medicine ,Humans ,Radiology, Nuclear Medicine and imaging ,bone scintigraphy ,Craniofacial ,Osteoblasts ,medicine.diagnostic_test ,business.industry ,Skull ,osteogenic and hyperostosis ,General Medicine ,Middle Aged ,medicine.disease ,99mTc-bisphosphonates ,medicine.anatomical_structure ,Bone scintigraphy ,Face ,030220 oncology & carcinogenesis ,Female ,medicine.symptom ,single-photon emission computed tomography/computed tomography ,business ,Nuclear medicine ,Emission computed tomography - Abstract
99mTc-bisphophonates bone scan, planar and single-photon emission computed tomography/computed tomography (SPECT/CT) modalities, is a commonly used technique that provides high sensitivity and specificity for detection of osseous metastases. However, besides bone metastases, SPECT/CT provides an accurate evaluation of the localization of the lesions and supplies anatomic information that can be valuable for diagnosis of nonmalignant bone diseases, occasionally disclosed in the skull. Reporting of craniofacial lesions detected by 99mTc-MDP (99mTc-labeled methylene diphosphonate) bone scintigraphy and SPECT/CT in the literature is limited. The aim of this pictorial review is to present the findings detected by 99mTc-MDP bone scintigraphy and SPECT/CT including cases under two broad categories: osteoblastic and hyperostosis craniofacial lesions.
- Published
- 2020